Emiko Kinoshita-Kikuta

Dr. Emiko Kinoshita-Kikuta

Department of Functional Molecular Science, Institute of Biomedical and Health Sciences, Hiroshima University, Kasumi 1-2-3, Hiroshima 734-8553, Japan
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2015 in Proteomes
Verified
Journal Article
Open access
PDF file
Eiji KinoshitaEiji Kinoshita
Eiji Kinoshita
Emiko Kinoshita-KikutaEmiko Kinoshita-Kikuta
Emiko Kinoshita-Kikuta
TKTohru Koike
Tohru Koike
Affinity electrophoresis is an important technique that is widely used to separate and analyze biomolecules in the fields of biology and medicine. Both quantitative and qualitative information can be gained through affinity electrophoresis. Affinity electrophoresis can be applied through a variety of strategies, such as mobility shift electrophoresis, charge shift electrophoresis or capillary affinity electrophoresis. These strategies are based on changes in the electrophoretic patterns of biological macromolecules that result from interactions or complex-formation processes that induce changes in the size or total charge of the molecules. Nucleic acid fragments can be characterized through their affinity to other molecules, for example transcriptional factor proteins. Hydrophobic membrane proteins can be identified by means of a shift in the mobility induced by a charged detergent. The various strategies have also been used in the estimation of association/disassociation constants. Some of these strategies have similarities to affinity chromatography, in that they use a probe or ligand immobilized on a supported matrix for electrophoresis. Such methods have recently contributed to profiling of major posttranslational modifications of proteins, such as glycosylation or phosphorylation. Here, we describe advances in analytical techniques involving affinity electrophoresis that have appeared during the last five years.

15 August 2017 in Sensors
Verified
Journal Article
Open access
PDF file
ASAkio Shiba
Akio Shiba
Emiko Kinoshita-KikutaEmiko Kinoshita-Kikuta
Emiko Kinoshita-Kikuta
Eiji KinoshitaEiji Kinoshita
Eiji Kinoshita
TKTohru Koike
Tohru Koike
We introduce two types of fluorescence-quenching assay for alkaline phosphatases (APs) by using a carboxytetramethyl-rhodamine (TAMRA)-labeled phosphate-binding tag molecule (TAMRA-Phos-tag). In the first assay, TAMRA-labeled O-phosphorylethanolamine (TAMRA-PEA) was used as an artificial AP-substrate. TAMRA-Phos-tag specifically captured TAMRA-PEA to form a 1:1 complex at pH 7.4; the intensity of the fluorescence peak of the complex at 580 nm (λex = 523 nm) was significantly reduced to 32% of the average value for the two individual components as a result of the mutual approach of the TAMRA moieties. As TAMRA-PEA was dephosphorylated by AP, the resulting TAMRA-labeled ethanolamine dissociated and the fluorescence increased in a manner dependent on the AP dose and the time. In the second assay, pyrophosphate (PP), a natural AP-substrate, was used as a bridging ligand to form a dimeric TAMRA-Phos-tag complex. The dimerization reduced the fluorescence intensity to 49% of that in the absence of PP. As pyrophosphate was hydrolyzed to two orthophosphate moieties by AP, the 580-nm fluorescence recovered in a time-dependent manner. By examining the initial slope of this time-dependent fluorescence recovery, we succeeded in evaluating the 50% inhibitory concentrations of orthovanadate toward two AP isozymes under near-physiological conditions.

2 October 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
Emiko Kinoshita-KikutaEmiko Kinoshita-Kikuta
Emiko Kinoshita-Kikuta
Eiji KinoshitaEiji Kinoshita
Eiji Kinoshita
MSMisaki Suga
Misaki Suga
MHMana Higashida
Mana Higashida
YYYuka Yamane
Yuka Yamane
TKTohru Koike
Tohru Koike
The production of heterologous proteins is an important procedure for biologists in basic and applied sciences. A variety of cell-based and cell-free protein expression systems are available to achieve this. The expression system must be selected carefully, especially for target proteins that require post-translational modifications. In this study, human Src family kinases were prepared using six different protein expression systems: 293 human embryonic kidney cells, Escherichia coli, and cell-free expression systems derived from rabbit reticulocytes, wheat germ, insect cells, or Escherichia coli. The phosphorylation status of each kinase was analyzed by Phos-tag SDS-PAGE. The kinase activities were also investigated. In the eukaryotic systems, multiple phosphorylated forms of the expressed kinases were observed. In the rabbit reticulocyte lysate system and 293 cells, differences in phosphorylation status between the wild-type and kinase-dead mutants were observed. Whether the expressed kinase was active depended on the properties of both the kinase and each expression system. In the prokaryotic systems, Src and Hck were expressed in autophosphorylated active forms. Clear differences in post-translational phosphorylation among the protein expression systems were revealed. These results provide useful information for preparing functional proteins regulated by phosphorylation.

25 July 2006 in Annals of Human Genetics
Verified
Journal Article
Open access
PDF file
YNYukiko Nakano
Yukiko Nakano
STSatoshi Tashiro
Satoshi Tashiro
EKEiji Kinoshita
Eiji Kinoshita
Emiko Kinoshita-KikutaEmiko Kinoshita-Kikuta
Emiko Kinoshita-Kikuta
STSou Takenaka
Sou Takenaka
KCKazuaki Chayama
Kazuaki Chayama
Recently, it has been reported that under 20% of Brugada syndrome cases are linked to SCN5A mutations. The purpose of this study was to clarify whether abnormalities other than exonic mutations, such as splicing disorders, decreased mRNA expression levels, or membrane transport abnormalities of SCN5A, play a role in the pathogenesis of Brugada syndrome. We analyzed all SCN5A exons and splice sites using genomic DNA from 23 Brugada syndrome patients. We also analyzed the mRNA obtained from RV cardiomyocytes using real time PCR and sequencing, to study the expression levels and splicing patterns of SCN5A. The localization of SCN5A was examined by immunofluorescence analysis. A de novo heterozygous G to A transversion in a 5′ splice junction of the intron between exons 21 and 22 was detected in 1 patient. In the mRNA analysis of Brugada syndrome patients without a mutation of SCN5A no splicing abnormalities were detected, and the SCN5A mRNA levels were similar to those of normal controls. Immunofluorescence analyses revealed that SCN5A is located on the surface membrane not only in the RV cardiomyocytes of normal controls but also in those with Brugada syndrome. We can confirm that some Brugada syndrome patients without exonic mutations in SCN5A had no other SCN5A abnormalities, including any involving the location of the SCN5A protein. These results suggest the involvement of other proteins in the pathogenesis in Brugada syndrome.

19 July 2024 in Kinases and Phosphatases
Verified
Journal Article
Open access
PDF file
Emiko Kinoshita-KikutaEmiko Kinoshita-Kikuta
Emiko Kinoshita-Kikuta
KNKento Nishikawa
Kento Nishikawa
KHKento Hiraishi
Kento Hiraishi
KSKaku Shimoji
Kaku Shimoji
KNKenichi Nagase
Kenichi Nagase
Eiji KinoshitaEiji Kinoshita
Eiji Kinoshita
The phosphorylation state of 20 types of intracellular proteins in the presence of the protein phosphatase 1 (PP1)- and PP2A-specific Ser/Thr phosphatase inhibitor calyculin A or the Tyr phosphatase inhibitor pervanadate was visualized by Phos-tag SDS-PAGE followed by immunoblotting. All blots showed a Phos-tag pattern indicating increased phosphorylation in the presence of one or both phosphatase inhibitors. The increase in phosphorylation stoichiometry per protein tends to be greater for Ser/Thr phosphatase inhibition than for Tyr phosphatase inhibition. This is consistent with the fact that the number of Ser/Thr kinase genes in the human genome is greater than that of Tyr kinases and with the fact that the phospho-Ser/phospho-Thr ratio in the actual human phosphoproteome is far greater than that of phospho-Tyr ratio. This suggests that cellular proteins are routinely and randomly phosphorylated by different kinases with no biological significance, simply depending on the frequency of substrate encounters. Phosphatase is responsible for routinely removing these unwanted phosphate groups systematically and maintaining the dynamic equilibrium of physiological protein phosphorylation. Phos-tag SDS-PAGE visualized that the kinase reaction involves many incidental phosphorylation and that phosphatases play broader roles besides being strict counterparts to kinases.

6 April 2021 in BioTechniques
Verified
Journal Article
Open access
Emiko Kinoshita-KikutaEmiko Kinoshita-Kikuta
Emiko Kinoshita-Kikuta
MYMomoka Yoshimoto
Momoka Yoshimoto
MYMarina Yano
Marina Yano
Eiji KinoshitaEiji Kinoshita
Eiji Kinoshita
TKTohru Koike
Tohru Koike
ABL, a human tyrosine protein kinase, and its substrate are co-expressed in Escherichia coli. Tyrosine phosphorylation of the substrate in E. coli was detected using Phos-tag SDS-PAGE. The bacteria... Graphical abstract METHOD SUMMARY This article describes an assay of tyrosine protein kinase ABL activity using an Escherichia coli protein expression system. Human tyrosine kinase ABL and its peptide substrate (Ablt...